U.S. markets close in 1 hour 24 minutes

Koninklijke Philips N.V. (PHIA.AS)

Amsterdam - Amsterdam Delayed Price. Currency in EUR
Add to watchlist
23.68+0.01 (+0.06%)
At close: 05:35PM CEST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close23.67
Bid0.00 x 0
Ask0.00 x 0
Day's Range23.49 - 23.85
52 Week Range21.65 - 46.91
Avg. Volume3,384,963
Market Cap20.589B
Beta (5Y Monthly)0.84
PE Ratio (TTM)6.78
Earnings DateN/A
Forward Dividend & Yield0.85 (3.59%)
Ex-Dividend DateMay 12, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for PHIA.AS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • GlobeNewswire

      Philips Foundation publishes its 2021 Annual Report

      Philips’ handheld point-of-care ultrasound platform Philips Foundation and SAS Brazil Philips Foundation working with Save the Children India May 25, 2022 Over 17 million people in underserved communities provided with access to quality healthcare in 2021 New social impact investment vehicle established to help nurture early-stage social enterprises Disaster relief in times of crisis highlighted by today’s humanitarian assistance to war-torn Ukraine, and projects responding to the COVID-19 pande

    • GlobeNewswire

      Philips showcases ultra-low contrast PCI solutions at EuroPCR 2022

      Philips Image Guided Therapy System – Azurion Philips intravascular ultrasound (IVUS) Philips iFR May 16, 2022 Co-registration of real-time intravascular ultrasound and/or iFR physiological assessment data onto motion-compensated angiograms aids percutaneous coronary intervention (PCI) procedure planning, quantitative lesion measurement, stent choice and sizing, and therapy assessmentReduced need for contrast media enables broader access to PCI for patients at risk of acute kidney injuryUltra-lo

    • GlobeNewswire

      New release of Philips EchoNavigator helps interventional teams treat structural heart disease with greater ease and efficiency

      Philips EchoNavigator 4.0 May 16, 2022 EchoNavigator 4.0 empowers heart teams with greater control of live fusion imaging plus new anatomical modeling and transseptal puncture guidance during minimally-invasive proceduresSeamless integration and communication between Philips Ultrasound System - EPIQ CVxi - and Philips Image Guided Therapy System - Azurion - supports efficient fusion-imaging workflow for minimally-invasive treatment of structural heart disease Amsterdam, the Netherlands – Royal P